EUVIMEDEUVIMED entdecken
Crossref

Testing the In-Vitro Product Performance of Nanomaterial-Based Drug Products: View of the USP Expert Panel

Matthias G Wacker, Xujin Lu, Matt Burke, lshai Nir, Raafat Fahmy

Dissolution Technologies · 2022 · 29 (1) · 6-20

DOI: 10.14227/dt290122p6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Dissolution Technologies, 2022. Verfasst von Matthias G Wacker und 4 weiteren Autor:innen. Die Arbeit wurde bisher 14-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Wacker, M. G., Lu, X., Burke, M., Nir, L., & Fahmy, R. (2022). Testing the In-Vitro Product Performance of Nanomaterial-Based Drug Products: View of the USP Expert Panel. Dissolution Technologies, 29(1), 6-20. https://doi.org/10.14227/dt290122p6

Vancouver

Wacker MG, Lu X, Burke M, Nir L, Fahmy R. Testing the In-Vitro Product Performance of Nanomaterial-Based Drug Products: View of the USP Expert Panel. Dissolution Technologies. 2022;29(1):6-20. doi:10.14227/dt290122p6

BibTeX
@article{Wacker2022,
  author = {Wacker, Matthias G and Lu, Xujin and Burke, Matt and Nir, lshai and Fahmy, Raafat},
  title = {Testing the In-Vitro Product Performance of Nanomaterial-Based Drug Products: View of the USP Expert Panel},
  journal = {Dissolution Technologies},
  year = {2022},
  volume = {29},
  number = {1},
  pages = {6--20},
  doi = {10.14227/dt290122p6}
}
Kostenlos starten →